Search results
Results from the WOW.Com Content Network
Description - includes the proprietary name (if any), nonproprietary name, dosage form(s), qualitative and/or quantitative ingredient information, the pharmacologic or therapeutic class of the drug, chemical name and structural formula of the drug, and if appropriate, other important chemical or physical information, such as physical constants ...
Structured Product Labeling (SPL) is a Health Level Seven International (HL7) standard which defines the content of human prescription drug labeling in an XML format. [1] The "drug labeling" includes all published material accompanying a drug, such as the Prescribing Information which contains a great deal of detailed information about the drug.
Template:Drugs for functional gastrointestinal disorders; Template:Drugs for obstructive airway diseases; Template:Drugs for peptic ulcer and GORD; Template:Drugs for treatment of bone diseases; Template:Drugs for treatment of hyperkalemia and hyperphosphatemia; Template:Drugs used in benign prostatic hypertrophy
DailyMed is a website operated by the U.S. National Library of Medicine (NLM) to publish up-to-date and accurate drug labels (also called a "package insert") to health care providers and the general public. The contents of DailyMed is provided and updated daily by the U.S. Food and Drug Administration (FDA). The FDA in turn collects this ...
Both sites work when using the brand name of the drug but the FDA site also allows searches with the generic name (active ingredient), which lists generic variants where they are licensed. Health Canada's site operates similarly to the FDA's site, with Canada-specific drug monographs and other information.
The template does not at the current time include summary information about the drug class itself. Instead, it contains a consistent interface to other sources that provide information about the drug class. Don't worry about trying to fill in all the fields – even if you can only get one or two, that still can be useful.
The benefit-risk profile of a drug varies in populations of different genomes, the study of which is known as pharmacogenomics. Pharmacogenomic testing can be performed to select patients for suitable clinical intervention. Incorporation of pharmacogenomic information in drug labels can help prevent adverse drug events and optimize drug dose.
[[Category:Drug templates]] to the <includeonly> section at the bottom of that page. Otherwise, add <noinclude>[[Category:Drug templates]]</noinclude> to the end of the template code, making sure it starts on the same line as the code's last character.